BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 29, 2006
View Archived Issues
Snapshots of newly reported clinical trials in leukemia, myelodysplastic syndromes: II
Read More
Encouraging clinical, preclinical data on siplizumab presented
Read More
Beta-lactamase inhibitor NXL-104 enters phase I
Read More
Imvamune equally immunogenic in HIV-infected subjects as healthy subjects
Read More
Positive data for Nastech's PYY(3-36) nasal spray
Read More
MK-0457 begins pivotal phase II study in treatment-resistant advanced leukemias
Read More
Introgen obtains license to patent applications covering INGN-241 uses
Read More
Recordati and sigma-tau to comarket new antihypertensive drug in Italy
Read More
New phase II trial investigates SNS-595 in ovarian cancer
Read More
Positive preliminary data for Oxycyte in traumatic brain injury
Read More
Data finalized from phase II study of talabostat plus docetaxel in NSCLC
Read More
NIAID to study Emergent's group B streptococcus vaccine candidate
Read More
YM partners with TTY in Taiwan for tesmilifene in hepatic cancer
Read More
Labopharm files complete response to once-daily tramadol approvable letter
Read More
Topline phase I findings for AZ-003
Read More
Encouraging findings for CTCE-0214 in healthy volunteers
Read More
Intranasal PH-80 provides significant improvements in PMS symptoms
Read More
Volinanserin enhances the antidepressant effects of desipramine and tranylcypromine in rats
Read More
Otsuka granted Japanese rights to saxagliptin
Read More
Faropenem phase III trial stopped to consider exclusion of Ketek arm
Read More
New phase II trial studies XL-880 in patients with gastric cancer
Read More
Valeant sells HIV and cancer programs to Ardea
Read More
Cimzia shows positive effect on ACR scores in rheumatoid arthritis
Read More
Preliminary findings from three Telcyta phase III studies
Read More
Clinical efficacy and safety of bifeprunox reported in patients with acute and stable schizophrenia
Read More
Novel agents for transplant rejection revealed in recent patents
Read More
Compounds for possible use in anxiety, depression, etc., claimed in recent patents
Read More